Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Metabolic Alkalosis in Ventilated COPD/OHS Patients
NCT01499485Phase 3Completed
- Sponsor
- Hospital Universitari Son Llàtzer
- Start
- Nov 2011
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetazolamide in metabolic alkalosis, sponsored by Hospital Universitari Son Llàtzer. Started Nov 2011; status: completed.
02
Drugs
acetazolamide
03
Conditions
metabolic alkalosis
Beyond the preview
Go deeper on NCT01499485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499485.